Galventa GmbH
Develops cutting edge nutraceutical and pharmaceutical products.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD5—7m (Dealroom.co estimates Oct 2021.)
Canton of St. Gallen Switzerland (HQ)
Financials
Estimates*
EUR | 2018 |
---|---|
Revenues | 4.4m |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | $354k | Convertible | |
€700k | Seed | ||
* | N/A | Grant | |
Total Funding | AUD1.7m |
Related Content
Recent News about Galventa GmbH
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.